2-naphthol has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, S; Chen, L; Hou, J; Wang, C; Xie, S; Zhao, Z | 1 |
1 other study(ies) available for 2-naphthol and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
Topics: Aged; Aged, 80 and over; Animals; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Disulfides; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Middle Aged; Naphthols; Neoplasm Metastasis; p21-Activated Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; RNA, Small Interfering | 2019 |